rs10804990
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020773.3(TBC1D14):c.-17-5439G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 151,978 control chromosomes in the GnomAD database, including 23,694 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.54 ( 23694 hom., cov: 32)
Consequence
TBC1D14
NM_020773.3 intron
NM_020773.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.309
Publications
7 publications found
Genes affected
TBC1D14 (HGNC:29246): (TBC1 domain family member 14) Enables protein kinase binding activity. Involved in negative regulation of autophagy; recycling endosome to Golgi transport; and regulation of autophagosome assembly. Located in several cellular components, including Golgi apparatus; autophagosome; and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.72 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TBC1D14 | ENST00000409757.9 | c.-17-5439G>A | intron_variant | Intron 1 of 13 | 1 | NM_020773.3 | ENSP00000386921.4 | |||
| TBC1D14 | ENST00000448507.5 | c.-17-5439G>A | intron_variant | Intron 1 of 13 | 5 | ENSP00000404041.1 | ||||
| TBC1D14 | ENST00000444368.1 | c.-17-5439G>A | intron_variant | Intron 1 of 1 | 3 | ENSP00000414951.1 | ||||
| TBC1D14 | ENST00000427736.1 | c.-17-5439G>A | intron_variant | Intron 1 of 1 | 2 | ENSP00000411760.1 |
Frequencies
GnomAD3 genomes AF: 0.545 AC: 82696AN: 151860Hom.: 23681 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
82696
AN:
151860
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.544 AC: 82729AN: 151978Hom.: 23694 Cov.: 32 AF XY: 0.549 AC XY: 40790AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
82729
AN:
151978
Hom.:
Cov.:
32
AF XY:
AC XY:
40790
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
14858
AN:
41412
American (AMR)
AF:
AC:
8472
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
2386
AN:
3468
East Asian (EAS)
AF:
AC:
3497
AN:
5160
South Asian (SAS)
AF:
AC:
3569
AN:
4820
European-Finnish (FIN)
AF:
AC:
6282
AN:
10556
Middle Eastern (MID)
AF:
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
AC:
41646
AN:
67998
Other (OTH)
AF:
AC:
1224
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1821
3643
5464
7286
9107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2339
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.